{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2025-09-19", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "codes": [ { "uuid": "4a67aa50-02d8-4eba-aa7f-c27e71942e51", "code": "C01BB01", "comments": "ATC|CARDIOVASCULAR SYSTEM|CARDIAC THERAPY|ANTIARRHYTHMICS, CLASS I AND III|Antiarrhythmics, class Ib|lidocaine", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=C01BB01&showdescription=yes", "code_system": "WHO-ATC", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "eba046b3-ded1-4e54-b5cf-af64218794aa", "code": "S02DA01", "comments": "ATC|SENSORY ORGANS|OTOLOGICALS|OTHER OTOLOGICALS|Analgesics and anesthetics|lidocaine", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=S02DA01&showdescription=yes", "code_system": "WHO-ATC", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "9f53ef77-4563-4b8a-86ed-cf43246a3cb8", "code": "R02AD02", "comments": "ATC|RESPIRATORY SYSTEM|THROAT PREPARATIONS|THROAT PREPARATIONS|Anesthetics, local|lidocaine", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=R02AD02&showdescription=yes", "code_system": "WHO-ATC", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "55350526-f0f6-4e16-ae2f-4ac5ea1d24a3", "code": "N01BB02", "comments": "ATC|NERVOUS SYSTEM|ANESTHETICS|ANESTHETICS, LOCAL|Amides|lidocaine", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=N01BB02&showdescription=yes", "code_system": "WHO-ATC", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "856addd6-f09c-460c-a065-6d1980dbfbf1", "code": "S01HA07", "comments": "ATC|SENSORY ORGANS|OPHTHALMOLOGICALS|LOCAL ANESTHETICS|Local anesthetics|lidocaine", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=S01HA07&showdescription=yes", "code_system": "WHO-ATC", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "7933cea3-3791-44ec-a1c1-1cabe64f79c8", "code": "D04AB01", "comments": "ATC|DERMATOLOGICALS|ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|Anesthetics for topical use|lidocaine", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=D04AB01&showdescription=yes", "code_system": "WHO-ATC", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "55904204-415d-4519-91d2-1a628a077663", "code": "C05AD01", "comments": "ATC|CARDIOVASCULAR SYSTEM|VASOPROTECTIVES|AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|Local anesthetics|lidocaine", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=C05AD01&showdescription=yes", "code_system": "WHO-ATC", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "6d847dc2-da79-46ac-9328-e3e8aaea49c3", "code": "N0000007681", "comments": "Chemical Ingredients [Chemical/Ingredient]|Organic Chemicals [Chemical/Ingredient]|Amides [Chemical/Ingredient]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000007681", "code_system": "NDF-RT", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "d009861c-7a43-4947-b3b6-ebc9c26bc6e8", "code": "N0000175682", "comments": "Established Pharmacologic Class [EPC]|Amide Local Anesthetic [EPC]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175682", "code_system": "NDF-RT", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "a04529fa-fb4e-4388-93b0-d56673a6c296", "code": "N0000175426", "comments": "Established Pharmacologic Class [EPC]|Antiarrhythmic [EPC]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175426", "code_system": "NDF-RT", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "367d4b82-6964-40f0-9913-c18278558553", "code": "N0000175976", "comments": "Physiological Effects [PE]|Organ System Specific Effects [PE]|Nervous System Activity Alteration [PE]|Peripheral Nervous System Activity Alteration [PE]|Sensory System Activity Alteration [PE]|Local Anesthesia [PE]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175976", "code_system": "NDF-RT", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "fda70825-23ef-489f-b1f2-40ea1f51275e", "code": "QR02AD02", "comments": "VATC|THROAT PREPARATIONS|THROAT PREPARATIONS|Anesthetics, local|lidocaine", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QR02AD02&showdescription=yes", "code_system": "WHO-VATC", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "97354875-884c-4157-a733-af429657c14a", "code": "QS01HA07", "comments": "VATC|OPHTHALMOLOGICALS|LOCAL ANESTHETICS|Local anesthetics|lidocaine", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QS01HA07&showdescription=yes", "code_system": "WHO-VATC", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "8f7d6d1b-97e1-48e5-88c3-0bb6dff8a9ca", "code": "QD04AB51", "comments": "VATC|ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|Anesthetics for topical use|lidocaine, combinations", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QD04AB51&showdescription=yes", "code_system": "WHO-VATC", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "c5181454-5353-4b7b-b0f8-62012063f5da", "code": "QN01BB52", "comments": "VATC|ANESTHETICS|ANESTHETICS, LOCAL|Amides|lidocaine, combinations", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QN01BB52&showdescription=yes", "code_system": "WHO-VATC", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "88572049-8318-4e61-a8fd-7f863f78f04d", "code": "QN01BB02", "comments": "VATC|ANESTHETICS|ANESTHETICS, LOCAL|Amides|lidocaine", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QN01BB02&showdescription=yes", "code_system": "WHO-VATC", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "58ae7f87-f561-482b-8797-c15cf7fb6033", "code": "QD04AB01", "comments": "VATC|ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|Anesthetics for topical use|lidocaine", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QD04AB01&showdescription=yes", "code_system": "WHO-VATC", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "ecf8024b-d361-49e0-a2cb-09c7a4e24ad1", "code": "QC05AD01", "comments": "VATC|VASOPROTECTIVES|AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|Local anesthetics|lidocaine", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QC05AD01&showdescription=yes", "code_system": "WHO-VATC", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "627720ac-91dc-414b-84f4-110a329e49c9", "code": "QC01BB01", "comments": "VATC|CARDIAC THERAPY|ANTIARRYTHMICS, CLASS I AND III|Antiarrhythmics, class Ib|lidocaine", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QC01BB01&showdescription=yes", "code_system": "WHO-VATC", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "64d7456a-4289-4444-b657-21ee6298ce91", "code": "QS02DA01", "comments": "VATC|OTOLOGICALS|OTHER OTOLOGICALS|Analgesics and anesthetics|lidocaine", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QS02DA01&showdescription=yes", "code_system": "WHO-VATC", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "fdd199d8-248c-4313-8fb2-81192764abb0", "code": "137-58-6", "type": "PRIMARY", "url": "https://commonchemistry.cas.org/detail?cas_rn=137-58-6", "code_system": "CAS", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47", "a3319834-2c76-4b26-98bb-7fa5ead59b7c" ] }, { "uuid": "0800197d-8c99-42f7-af17-fea2c2757555", "code": "C614", "type": "PRIMARY", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C614", "code_system": "NCI_THESAURUS", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "d7e6b59e-274d-41a9-8ca9-2d734815ca45", "code": "D008012", "type": "PRIMARY", "url": "http://www.ncbi.nlm.nih.gov/mesh/68008012", "code_system": "MESH", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "02ea755b-9211-41d9-80ac-10bfa57c231d", "code": "1.2 (LID/EPI)", "comments": "WHO ESSENTIAL MEDICINES LIST|Anaesthetics|Local anaesthetics", "type": "PRIMARY", "url": "http://prais.paho.org/medicine/14/?section=31#type32", "code_system": "WHO-ESSENTIAL MEDICINES LIST", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "1a1a323c-b941-45a0-8551-de800bc567e1", "code": "1.2", "comments": "WHO ESSENTIAL MEDICINES LIST|Anaesthetics|Local anaesthetics", "type": "PRIMARY", "url": "http://prais.paho.org/medicine/13/?section=31#type27", "code_system": "WHO-ESSENTIAL MEDICINES LIST", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "670b7570-f63b-4e3c-bd4e-3fffa5a25013", "code": "21 CFR 346.10", "comments": "PART 346 -- ANORECTAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE|Subpart B--Active Ingredients|Sec. 346.10 Local anesthetic active ingredients.", "type": "PRIMARY", "url": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=346.10", "code_system": "CFR", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "e8b17db9-9ca8-4d31-b68a-d49ae692436e", "code": "LIDOCAINE", "type": "PRIMARY", "url": "https://en.wikipedia.org/wiki/Lidocaine", "code_system": "WIKIPEDIA", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "de2d9459-12ce-4975-bc49-2d01af6831c3", "code": "12.2", "comments": "WHO ESSENTIAL MEDICINES LIST|Cardiovascular medicines|Antiarrhythmic medicines", "type": "PRIMARY", "url": "http://prais.paho.org/medicine/13/?section=92#type29", "code_system": "WHO-ESSENTIAL MEDICINES LIST", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "1c6be091-cb85-4ebb-94a1-8c2e6f2091c9", "code": "21 CFR 348.10", "comments": "PART 348 -- EXTERNAL ANALGESIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE|Subpart B--Active Ingredients|Sec. 348.10 Analgesic, anesthetic, and antipruritic active ingredients.", "type": "PRIMARY", "url": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=348.10", "code_system": "CFR", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "640334ee-f018-4d2a-be8a-17094437976a", "code": "N01BB52", "comments": "ATC|NERVOUS SYSTEM|ANESTHETICS|ANESTHETICS, LOCAL|Amides|lidocaine, combinations", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=N01BB52&showdescription=yes", "code_system": "WHO-ATC", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "27116aa4-5e88-4b60-93c4-f7c745b02654", "code": "21 CFR 522.810", "comments": "PART 522 IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS|\"Sec. 522.810 \"\"Embutramide, chloroquine, and lidocaine solution.\"\"\"", "type": "PRIMARY", "url": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=522.810", "code_system": "CFR", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "afbceb1c-a535-407a-9efc-30605a8d55f2", "code": "21 CFR 522.1662B", "comments": "PART 522 IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS|Sec. 522.1662b Oxytetracycline hydrochloride with lidocaine injection.", "type": "PRIMARY", "url": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=522.1662b", "code_system": "CFR", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "d5e1405e-86a4-4a5b-b804-bd227fb62a7a", "code": "SUB08507MIG", "type": "PRIMARY", "code_system": "EVMPD", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "20ac5f2d-0507-491a-8ada-a2fc9b53dfab", "code": "4202", "type": "PRIMARY", "url": "https://extranet.who.int/soinn/mod/page/view.php?id=137&inn_n=4202", "code_system": "INN", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "e6b78adc-a0a8-4b1a-86d9-af5b6e94385e", "code": "FORTACIN (AUTHORIZED: SEXUAL DYSFUNCTION, PHYSIOLOGICAL)", "comments": "EMA EPAR|DISEASES|MALE DISEASES OF THE UIRINARY AND REPRODUCTIVE SYSTEMS|GENITAL DISEASES, MALE|SEXUAL DYSFUNCTION, PHYSIOLOGCIAL", "type": "PRIMARY", "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002693/human_med_001704.jsp&mid=WC0b01ac058001d124", "code_system": "EMA ASSESSMENT REPORTS", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "067628ff-d8c9-4c37-8310-60ba484ddc5f", "code": "205-302-8", "type": "PRIMARY", "url": "https://echa.europa.eu/substance-information/-/substanceinfo/100.004.821", "code_system": "ECHA (EC/EINECS)", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "8aa62ec4-d153-4880-b4e1-dda827cdf1cb", "code": "2623", "type": "PRIMARY", "url": "http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2623", "code_system": "IUPHAR", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "416f5f22-839a-40d3-9139-bceec946a3af", "code": "LIDOCAINE", "comments": "Description: A white or slightly yellow, crystalline powder; odour, characteristic. Solubility: Practically insoluble in water; very soluble in ethanol (~750 g/l) TS; freely soluble in benzene R and ether R. Category: Local anaesthetic. Storage: Lidocaine should be kept in a tightly closed container, protected from light. Additional information: Lidocaine causes local numbness after being placed on the tongue. Definition: Lidocaine contains not less than 99.0% and not more than 101.0% of C14H22N2O, calculated with reference to the dried substance.", "type": "PRIMARY", "url": "http://apps.who.int/phint/pdf/b/Jb.6.1.244.pdf", "code_system": "WHO INTERNATIONAL PHARMACOPEIA", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "2b6e13e5-cb33-4a3a-809d-b2fc4e83047e", "code": "6387", "comments": "RxNorm", "type": "PRIMARY", "url": "https://rxnav.nlm.nih.gov/REST/rxcui/6387/allProperties.xml?prop=all", "code_system": "RXCUI", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "1ace10f9-c28d-4078-b15e-8805645d7d93", "code": "m6805", "comments": "Merck Index", "type": "PRIMARY", "url": "https://merckindex.rsc.org/monographs/m6805?q=authorize", "code_system": "MERCK INDEX", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "5ecb2304-54c6-4af1-9bee-5eaac7efbe87", "code": "DB00281", "type": "PRIMARY", "url": "http://www.drugbank.ca/drugs/DB00281", "code_system": "DRUG BANK", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "5dfaf6a1-7864-4334-97a6-cac71bf51250", "code": "21 CFR 862.3555", "comments": "PART 862 -- CLINICAL CHEMISTRY AND CLINICAL TOXICOLOGY DEVICES|Subpart D--Clinical Toxicology Test Systems|Sec. 862.3555 Lidocaine test system.", "type": "PRIMARY", "url": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=862.3555", "code_system": "CFR", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "85c463d9-68dc-4838-b917-97c4f7a51ff5", "code": "CHEMBL79", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL79", "code_system": "ChEMBL", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "1b42795b-3ce2-4afc-9f98-e6ccf5dba7e8", "code": "3676", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3676", "code_system": "PUBCHEM", "references": [ "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47" ] }, { "uuid": "6b246c1e-b1d5-0cb0-7193-014e8a328cee", "code": "91484-71-8", "type": "SUPERSEDED", "url": "https://commonchemistry.cas.org/detail?cas_rn=91484-71-8", "code_system": "CAS", "references": [ "a3319834-2c76-4b26-98bb-7fa5ead59b7c" ] }, { "uuid": "00d5a13d-6290-ffe4-e80d-6e95724cb3d2", "code": "3350", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3350", "code_system": "HSDB", "references": [ "78d633b9-53a8-4dd8-cc6a-cdd1a45a52c8" ] }, { "uuid": "07bef2d4-be25-9edc-711d-3dda1b1b1d95", "code": "DTXSID1045166", "type": "PRIMARY", "url": "https://comptox.epa.gov/dashboard/chemical/details/DTXSID1045166", "code_system": "EPA CompTox", "references": [ "8009d5db-f5bb-f791-ca24-76302a54fd24" ] }, { "uuid": "75057c59-b205-70d6-06b9-c112b3a4896f", "code": "92395", "comments": "ORPHAN DRUG|Designated/Approved|For relief of allodynia (painful hypersensitivity), and chronic pain in postherpetic neuralgia.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=92395", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "437f0156-df2f-d225-26dc-01bfc74d1de2", "code": "C245", "comments": "Pharmacologic Substance[C1909]|Agent Affecting Nervous System[C78272]|Anesthetic Agent", "type": "CONCEPT", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C245", "code_system": "NCI_THESAURUS", "references": [ "8bdadee5-9cb3-f715-821a-8d877fa566d6" ] }, { "uuid": "d2ad47b0-5a64-3083-9e0c-459cb9c836a6", "code": "C93038", "comments": "Pharmacologic Substance[C1909]|Cation Channel Blocker", "type": "CONCEPT", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C93038", "code_system": "NCI_THESAURUS", "references": [ "8bdadee5-9cb3-f715-821a-8d877fa566d6" ] }, { "uuid": "99f749e9-e373-4d1f-9579-ff61f52e9ddc", "code": "98PI200987", "type": "PRIMARY", "code_system": "FDA UNII" }, { "uuid": "aa17b360-146a-110b-2471-f59f8a04d3f2", "code": "Lidocaine", "type": "PRIMARY", "url": "https://www.ncbi.nlm.nih.gov/books/n/lactmed/LM363/", "code_system": "LACTMED", "references": [ "8bdadee5-9cb3-f715-821a-8d877fa566d6" ] }, { "uuid": "5493ed72-9ae1-478a-db1c-b01dbe1c5456", "code": "1579", "type": "PRIMARY", "url": "https://drugcentral.org/drugcard/1579", "code_system": "DRUG CENTRAL", "references": [ "8bdadee5-9cb3-f715-821a-8d877fa566d6" ] }, { "uuid": "fc8fee11-68bf-1a46-1cda-775b8670380f", "code": "6456", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chebi/chebiOntology.do?chebiId=CHEBI:6456", "code_system": "CHEBI", "references": [ "8bdadee5-9cb3-f715-821a-8d877fa566d6" ] }, { "uuid": "bafe2378-47e9-deef-04a6-6829be3ad08a", "code": "1366002", "type": "PRIMARY", "url": "https://store.usp.org/product/1366002", "code_system": "RS_ITEM_NUM", "references": [ "8bdadee5-9cb3-f715-821a-8d877fa566d6" ] }, { "uuid": "c54e3ab0-79f3-aaa0-27eb-906e281170c3", "code": "98PI200987", "type": "PRIMARY", "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?adv=1&query=98PI200987", "code_system": "DAILYMED", "references": [ "5661bacd-6b45-ea64-88ae-4a961ccae7c8" ] }, { "uuid": "77b518fa-3b89-4801-3ec0-33d3956b1ce2", "code": "100000091713", "type": "PRIMARY", "code_system": "SMS_ID", "references": [ "d4a8d68d-7fcd-ac26-15a6-dbf15eed0bf5" ] }, { "uuid": "b4fdc5e2-27a5-f73b-207f-faf788235979", "code": "40030", "type": "PRIMARY", "url": "https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=40030", "code_system": "NSC", "references": [ "96d1360c-4159-2a2c-6de2-9b346d5926a4" ] } ], "substance_class": "chemical", "references": [ { "uuid": "666c86b6-49e5-47af-9b82-441e9756cc3e", "citation": "USP42-NF37 - 2567, Lidocaine Monograph", "doc_type": "USPNF", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE", "NOMEN" ] }, { "uuid": "9a675430-629d-5c59-447b-4e55c41fe29b", "citation": "USP42-NF37 - 2567, Lidocaine Monograph", "doc_type": "USPNF", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "8c7df00d-271a-e555-8280-d90d2b844aeb", "citation": "European Pharmacopoeia Online 9.8, Lidocaine Monograph", "doc_type": "EP", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "8793fe37-1d7c-4ba3-8ee4-9a00f8d8ae2b", "citation": "USP-NF", "doc_type": "USPNF", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE", "NOMEN" ] }, { "uuid": "ae859173-e1aa-4942-b302-1d5b3fa6de36", "citation": "USP Dictionary 2008", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE", "AUTO_SELECTED" ] }, { "uuid": "fa2728bf-222f-4ae5-aec0-54df9414ebb4", "citation": "usp dictionary 2008", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "f0ed48fb-7e10-491e-8af0-7dea864e7ed7", "citation": "Merck 14.3", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "5eef161b-6bd8-4a55-bbac-39a361265896", "citation": "USP DICTIONARY 2010", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "3c79f50c-8d3a-454f-b214-47d68fa85576", "citation": "ORANGE BOOK", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "78b6ba3a-0c92-449d-9c02-ddac1af84d86", "citation": "INN Proposed List 1", "url": "https://www.who.int/medicines/publications/druginformation/innlists/PL01.pdf", "doc_type": "INN_LIST", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "229076c8-1cf3-4d4c-b621-77e044790772", "citation": "EP 7.2", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "156354d8-1525-46d6-a6ca-4e3a8244942c", "citation": "USP 33", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "30b82b41-ff34-48a0-a941-b52489a84686", "citation": "Drugs@FDA 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "a8fb229b-6c4d-42c1-a217-1cbf70c741b2", "citation": "Drugs@FDA 2012", "doc_type": "DRUGS@FDA", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "7eaa5290-1f2f-46e2-b64b-6bb81415215a", "citation": "ORANGE BOOK 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "b9715576-c29a-4d1a-9c06-95f3deb58b0a", "citation": "MARTINDALE 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "b3f4863a-abae-4924-bd65-c00c704d8ec6", "citation": "MERCK INDEX", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "8d42964d-c89a-415d-a435-8c97425aae2e", "citation": "FDA SRS 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "b6fdacc6-7cb2-4ef3-bf20-d131eb5d1cf6", "citation": "PCPC", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "05187042-7df8-4be4-82d9-381e740b7780", "citation": "HSDB", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "24a5ca0b-47ba-4b43-8e07-4984598abeba", "citation": "USP/NF", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "212c8c7e-5672-41a1-93b1-705f9f46c352", "citation": "WHO-DD", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "5fbfd2f4-3b15-4451-afc8-59a478de2b67", "citation": "CLINICAL TRIALS", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "b51c8423-411f-4f38-85ca-69fad4b9193d", "citation": "NDF-RT", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "a3cf2787-de43-4015-bb3f-b1198fb066b5", "citation": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002693/human_med_001704.", "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002693/human_med_001704.", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "cd9a9ace-ab5f-402b-8d40-78fe7472ce38", "citation": "WHO-IP", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "f24e59fb-762f-4fdf-a7ce-792c9a2e0035", "citation": "SCIFINDER", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "a8dec92f-7b9b-430f-a2d3-9d4b1d68eb47", "citation": "SRS CODE IMPORT", "doc_type": "SRS", "public_domain": true, "document_date": 1493389722000, "tags": [ "NOMEN" ] }, { "uuid": "0ad4610c-3ce1-4a3f-bf38-072b8bdf5217", "citation": "EP 7.8 LIDOCAINE MONOGRAPH", "doc_type": "EUROPEAN PHARMACOPEIA", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "a8b6b682-559b-4d88-9ac3-ab34e1a0eb14", "citation": "USP 36 LIDOCAINE MONOGRAPH", "doc_type": "USP", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "1405535c-8fe2-4c8f-9eef-8bcda9aef23a", "citation": "http://www.accessdata.fda.gov/spl/data/092120c9-7f98-4411-a0bc-e64dbd586ac9/092120c9-7f98-4411-a0bc-e64dbd586ac9.xml", "url": "http://www.accessdata.fda.gov/spl/data/092120c9-7f98-4411-a0bc-e64dbd586ac9/092120c9-7f98-4411-a0bc-e64dbd586ac9.xml", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "04b4ced8-66be-4dbe-b960-c45539c376f6", "citation": "CLINICAL PHARMACOLOGY & THERAPEUTICS [0009-9236] DRAYER, DENNIS YR:1983 VOL:34 ISS:1 PG:14 -22", "url": "http://www.nature.com/clpt/journal/v34/n1/pdf/clpt1983122a.pdf", "doc_type": "JOURNAL ARTICLE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "d3ace912-d54f-4d51-91f0-f2ae11e957e4", "citation": "CLINICAL PHARMACOLOGY AND THERAPEUTICS (1989) 46, 521?527; DOI:10.1038/CLPT.1989.180", "url": "http://www.nature.com/clpt/journal/v46/n5/pdf/clpt1989180a.pdf", "doc_type": "JOURNAL ARTICLE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "17e4df00-904b-4c5f-bad9-c0cacef99e1c", "citation": "HANDBOOK OF CLINICAL PHARMACOKINETICS; EDS MILO GIBALDI AND LAURIE PRESCOTT; ADIS HEALTH SCIENCE PRESS; ISBN 0 86792 004 1; 1983", "doc_type": "BOOK", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "e158ae36-c94d-4fd7-b3af-a6969704379f", "citation": "SRS import [98PI200987]", "url": "http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=98PI200987", "doc_type": "SRS", "public_domain": true, "document_date": 1493389722000, "tags": [ "NOMEN" ] }, { "uuid": "60d56384-5fae-4b57-b1bb-98d5d8f925e1", "citation": "USP Dictionary 2010", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "22da41c7-5dc9-4e7d-bbb8-0c8bd257bf6c", "citation": "LIDOCAINE [INN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "8087e2a9-1e5f-492a-a447-9970b0c19645", "citation": "LIDOCAINE [EP]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "57eda33a-f62d-4543-82f0-cc272f0ec4c1", "citation": "LIDOCAINE [USP]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "bef4f229-e00d-43bc-9823-c39ee3fe8987", "citation": "LIDOCAINE [ORANGE BOOK]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "e181bd06-4d42-45a2-a28f-f1a28a01fdb5", "citation": "LIDOCAINE [MART.]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "b3d1377e-0b7f-4787-a50e-9208fc9f5106", "citation": "LIDOCAINE [MI]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "e40e9af9-1428-4931-988a-f4cf5be33465", "citation": "LIDOCAINE [GREEN BOOK]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "b031dbc7-c397-487e-9407-a25ff007aca9", "citation": "LIDOCAINE [INCI]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "cf74b85b-cf89-4454-bcc2-3eccb42c3480", "citation": "LIDOCAINE [HSDB]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "717312e4-de02-4022-bdb4-47b42d535afc", "citation": "LIDOCAINE [USP-RS]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "88d8b0da-1ba9-4764-9eed-562f3100580a", "citation": "LIDOCAINE [WHO-DD]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "1a3ab3e9-998e-42aa-8c35-79aec4ca26a3", "citation": "LIDOCAINE [VANDF]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "cfedf5c5-e1e5-461e-bb5a-fcb2032fdb17", "citation": "LIDOCAINE [WHO-IP]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "5b2a32d8-db87-41b8-9ace-4da9eccf6748", "citation": "WIKIPEDIA", "doc_type": "WIKI", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE", "NOMEN" ] }, { "uuid": "8f1cba26-4d47-6baa-c8f6-375c09baba84", "citation": "JAN", "doc_type": "SRS", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE", "NOMEN" ] }, { "uuid": "94df265b-277c-e42a-6ff0-93b8c5c892cf", "citation": "Pharmacol Rev 65:578–640, April 2013", "url": "http://dx.doi.org/10.1124/pr.111.005439", "doc_type": "JA", "public_domain": true }, { "uuid": "78d633b9-53a8-4dd8-cc6a-cdd1a45a52c8", "citation": "WEBSITE", "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@rn+@rel+137-58-6", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "8009d5db-f5bb-f791-ca24-76302a54fd24", "citation": "WEBSITE", "url": "https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=137-58-6", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "7d5dcbfa-7656-f94b-570d-867975891526", "citation": "WEBSITE", "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+lactmed:@term+@rel+@rn+137-58-6", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "2e460475-fb38-3986-9487-e1b4763ae2ae", "citation": "DM", "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a1b17507-4560-490d-a388-74e7fd7eaa5e", "doc_type": "DAILYMED", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE", "DBE" ] }, { "uuid": "d4a8d68d-7fcd-ac26-15a6-dbf15eed0bf5", "citation": "EU-SRS", "doc_type": "EMA LIST", "public_domain": true }, { "uuid": "af3ee059-b0ca-9538-ce62-3146e0ca47c4", "citation": "Drug Information Handbook, 2016-2017 - 25th edition; Lexicomp Drug Reference Handbook; ISBN13: 9781591953531", "doc_type": "BOOK", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "f25e8b21-c5c8-4488-ffeb-29d4bf08f7d7", "citation": "2014-005207-25-GB", "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005207-25/GB", "doc_type": "CLINICALTRIALS", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "e4beb22e-ffd9-0145-c93b-ef005bf98323", "citation": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022060-13/BG", "doc_type": "EU CLINICAL TRIALS", "public_domain": true }, { "uuid": "8bdadee5-9cb3-f715-821a-8d877fa566d6", "doc_type": "SYSTEM", "public_domain": true }, { "uuid": "b2bbe579-8933-474c-b2e4-e6f1d1f97930", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true }, { "uuid": "a3319834-2c76-4b26-98bb-7fa5ead59b7c", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true }, { "uuid": "43528574-f9e6-48bd-87f2-627674417232", "citation": "Higuchi, Ryota, et al. \"Prilocaine-and lidocaine-induced methemoglobinemia is caused by human carboxylesterase-, CYP2E1-, and CYP3A4-mediated metabolic activation.\" Drug Metabolism and Disposition 41.6 (2013): 1220-1230.", "url": "http://dmd.aspetjournals.org/content/dmd/41/6/1220.full.pdf", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "7b3e29ca-fabb-69a7-09e6-cc269c919a83", "citation": "Higuchi, Ryota, et al. \"Prilocaine-and lidocaine-induced methemoglobinemia is caused by human carboxylesterase-, CYP2E1-, and CYP3A4-mediated metabolic activation.\" Drug Metabolism and Disposition 41.6 (2013): 1220-1230.", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "1e040dbe-12b8-4ab1-a250-528b748be901", "citation": "Higuchi, Ryota, et al. \"Prilocaine-and lidocaine-induced methemoglobinemia is caused by human carboxylesterase-, CYP2E1-, and CYP3A4-mediated metabolic activation.\" Drug Metabolism and Disposition 41.6 (2013): 1220-1230.", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "e8f8d5c4-fcc0-42ef-a209-aec5b3f6bdb9", "citation": "Thromb Res 1985;38(1):33", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "aa3c238b-a374-44c8-a26e-14d83f308d67", "citation": "J Pharmacol Exp Ther 179(3):580;1971", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "8b7c555e-33e1-4cb1-ae8d-3aa1a6f42265", "citation": "Pharmacol Rev 65:578–640, April 2013", "url": "http://dx.doi.org/10.1124/pr.111.005439", "doc_type": "JA", "public_domain": true }, { "uuid": "24785329-1e93-43e5-8489-a79fc52eb0f9", "citation": "J Pharm Pharmacol 26(11):889;1974", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "e75ba3b1-d99d-f05b-6d5a-6f1f2571487e", "citation": "USP 10/2020", "doc_type": "USPNF", "public_domain": true }, { "uuid": "809499b3-0580-1c2f-38e3-cdac7758b67b", "citation": "EP 10.5", "doc_type": "EP", "public_domain": true }, { "uuid": "30f68adc-03b7-48c7-9a40-03c10de2fb0a", "citation": "Higuchi, Ryota, et al. \"Prilocaine-and lidocaine-induced methemoglobinemia is caused by human carboxylesterase-, CYP2E1-, and CYP3A4-mediated metabolic activation.\" Drug Metabolism and Disposition 41.6 (2013): 1220-1230.", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "96d1360c-4159-2a2c-6de2-9b346d5926a4", "citation": "NCI", "doc_type": "NCI DRUG DICTIONARY", "public_domain": true }, { "uuid": "5661bacd-6b45-ea64-88ae-4a961ccae7c8", "citation": "DailyMed", "doc_type": "DAILYMED", "public_domain": true }, { "uuid": "7ac5392d-6b44-5fb1-1be2-d43d18604232", "citation": "WHO-DD", "doc_type": "WHO DRUG DICTIONARY", "public_domain": true }, { "uuid": "29c12beb-88f1-43fa-a1aa-88ce0cadb012", "citation": "Routledge, P. A., et al. \"Lidocaine plasma protein binding.\" Clinical Pharmacology & Therapeutics 27.3 (1980): 347-351.", "url": "https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1038/clpt.1980.46", "doc_type": "JA", "public_domain": true }, { "uuid": "e359e2c5-a498-4f41-add6-d2c5641b1434", "citation": "Yang, Xi, et al. \"A review of the mechanism of the central analgesic effect of lidocaine.\" Medicine 99.17 (2020).", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440315/#:~:text=In%20summary%2C%20lidocaine%20acts%20on,and%20affects%20the%20discharge%20frequency", "doc_type": "JA", "public_domain": true } ], "definition_type": "PRIMARY", "moieties": [ { "uuid": "57b36324-d5d9-4515-810c-7bd3f699ffe1", "id": "57b36324-d5d9-4515-810c-7bd3f699ffe1", "molfile": "\n Marvin 01132104332D \n\n 17 17 0 0 0 0 999 V2000\n 5.4022 -2.1854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 4.9733 -2.8364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 4.1155 -2.8364 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 3.7223 -3.5411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.9130 -3.5411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.7223 -2.1471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.8952 -2.1598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.5760 -2.7113 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 2.5505 -1.4424 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 1.6876 -1.4424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.2587 -0.7378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.6722 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.4009 -0.7378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.0000 -1.4424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.4239 -2.1471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.2587 -2.1471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.6722 -2.8952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1 2 1 0 0 0 0\n 2 3 1 0 0 0 0\n 4 3 1 0 0 0 0\n 3 6 1 0 0 0 0\n 5 4 1 0 0 0 0\n 6 7 1 0 0 0 0\n 8 7 2 0 0 0 0\n 7 9 1 0 0 0 0\n 9 10 1 0 0 0 0\n 11 10 1 0 0 0 0\n 16 10 2 0 0 0 0\n 12 11 1 0 0 0 0\n 13 11 2 0 0 0 0\n 13 14 1 0 0 0 0\n 14 15 2 0 0 0 0\n 15 16 1 0 0 0 0\n 17 16 1 0 0 0 0\nM END", "smiles": "CCN(CC)CC(=O)Nc1c(C)cccc1C", "formula": "C14H22N2O", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "ACHIRAL", "count_amount": { "type": "MOL RATIO", "average": 1, "units": "MOL RATIO", "uuid": "922bb7ba-e583-46db-b54e-e27f92c5ac30" }, "defined_stereo": 0, "ez_centers": 0, "molecular_weight": "234.3378", "optical_activity": "NONE", "stereo_centers": 0 } ], "definition_level": "COMPLETE", "uuid": "087f7c29-e973-41b7-889e-7952d8b02364", "version": "70", "structure": { "id": "c5f44a8e-4b2a-4369-85fa-aefcf490d4bf", "molfile": "\n Marvin 01132110142D \n\n 17 17 0 0 0 0 999 V2000\n 1.6876 -1.4424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.5505 -1.4424 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 2.8952 -2.1598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.2587 -0.7378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.2587 -2.1471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.5760 -2.7113 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 3.7223 -2.1471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 4.1155 -2.8364 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 0.0000 -1.4424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.4239 -2.1471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.4009 -0.7378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.6722 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.6722 -2.8952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 4.9733 -2.8364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.7223 -3.5411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 5.4022 -2.1854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.9130 -3.5411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2 1 1 0 0 0 0\n 3 2 1 0 0 0 0\n 4 1 2 0 0 0 0\n 5 1 1 0 0 0 0\n 6 3 2 0 0 0 0\n 7 3 1 0 0 0 0\n 8 7 1 0 0 0 0\n 9 10 1 0 0 0 0\n 10 5 2 0 0 0 0\n 11 4 1 0 0 0 0\n 12 4 1 0 0 0 0\n 13 5 1 0 0 0 0\n 14 8 1 0 0 0 0\n 15 8 1 0 0 0 0\n 16 14 1 0 0 0 0\n 17 15 1 0 0 0 0\n 11 9 2 0 0 0 0\nM END", "smiles": "CCN(CC)CC(=O)Nc1c(C)cccc1C", "formula": "C14H22N2O", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "ACHIRAL", "defined_stereo": 0, "ez_centers": 0, "molecular_weight": "234.3378", "optical_activity": "NONE", "references": [ "e158ae36-c94d-4fd7-b3af-a6969704379f", "60d56384-5fae-4b57-b1bb-98d5d8f925e1", "78b6ba3a-0c92-449d-9c02-ddac1af84d86" ], "stereo_centers": 0 }, "unii": "98PI200987", "relationships": [ { "uuid": "90a6c00a-b11a-427b-88e4-98ed76eb5a14", "amount": { "uuid": "8a796f1c-7dae-44f7-bb18-b328fd7e6ef1" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "a33277fc-f66a-45af-9535-7d20b03340a9", "refuuid": "c7e5cab4-89d1-41fa-abf7-42f49aed1785", "name": "LIDOCAINE BICARBONATE", "unii": "2DO9G6G1JY", "linking_id": "2DO9G6G1JY", "ref_pname": "LIDOCAINE BICARBONATE", "substance_class": "reference" } }, { "uuid": "28f785cc-db8e-4aaa-81b2-e720e08526bd", "amount": { "uuid": "7990b1c8-613b-423c-b240-25af530723b0" }, "qualification": "PLASMA", "type": "METABOLITE ACTIVE->PARENT", "interaction_type": "MAJOR", "mediator_substance": { "uuid": "aaaa1528-b68f-43b9-a87f-cadc11ff0c3b", "refuuid": "4275827d-e329-4907-95b5-7d690692872a", "name": "CYTOCHROME P450 3A4", "unii": "PUO0521HZV", "linking_id": "PUO0521HZV", "ref_pname": "CYTOCHROME P450 3A4", "substance_class": "reference" }, "references": [ "aa3c238b-a374-44c8-a26e-14d83f308d67" ], "related_substance": { "uuid": "02b4fcc1-668f-4cd3-a44d-2da00eba46e5", "refuuid": "d59d04c1-0979-4a84-8854-5938cd32ba1a", "name": "NORLIDOCAINE", "unii": "D8Q99HC770", "linking_id": "D8Q99HC770", "ref_pname": "NORLIDOCAINE", "substance_class": "reference" } }, { "uuid": "ca8be47f-2bf2-4432-9ac2-5a4eeff04b19", "amount": { "uuid": "6aceebcb-1a2c-48e5-9f33-6f59c13e13cc" }, "comments": "Adversely affected mental performance and caused headaches in man.", "type": "METABOLITE TOXIC->PARENT", "references": [ "17e4df00-904b-4c5f-bad9-c0cacef99e1c" ], "related_substance": { "uuid": "d82594e5-41f7-4b84-b8a2-c2d944951731", "refuuid": "21399087-587f-495d-90e9-66fce856fcca", "name": "ACETYLHYDRAZINE", "unii": "SK0DPC9098", "linking_id": "SK0DPC9098", "ref_pname": "ACETYLHYDRAZINE", "substance_class": "reference" } }, { "uuid": "39d6fd9e-2ca2-4b1c-9a0c-219349cb60a9", "amount": { "uuid": "b1fe7fe5-6fb7-4b9c-8832-1d3607e256cb" }, "type": "ACTIVE MOIETY", "related_substance": { "uuid": "22741e9c-2ee5-475e-a6bc-6a5eeeadbc08", "refuuid": "087f7c29-e973-41b7-889e-7952d8b02364", "name": "LIDOCAINE", "unii": "98PI200987", "linking_id": "98PI200987", "ref_pname": "LIDOCAINE", "substance_class": "reference" } }, { "uuid": "78e62afa-e2bc-4c9b-8a8d-0e089159ed54", "amount": { "uuid": "f48c6ffc-1b3c-4f56-a56d-76ebce791e2c", "type": "RELATIONSHIP_AMOUNT", "units": "WEIGHT PERCENT", "high_limit": 101, "low_limit": 99 }, "qualification": "EP", "type": "BASIS OF STRENGTH->SUBSTANCE", "interaction_type": "ASSAY (TITRATION)", "references": [ "0ad4610c-3ce1-4a3f-bf38-072b8bdf5217" ], "related_substance": { "uuid": "022d6c25-1422-4410-af82-d8c5e2c6a12d", "refuuid": "087f7c29-e973-41b7-889e-7952d8b02364", "name": "LIDOCAINE", "unii": "98PI200987", "linking_id": "98PI200987", "ref_pname": "LIDOCAINE", "substance_class": "reference" } }, { "uuid": "7f0c90db-f74d-4f15-85df-117528c68650", "amount": { "uuid": "2bb36d2b-2987-47b9-ae67-80eeac91f62f", "type": "RELATIONSHIP_AMOUNT", "units": "WEIGHT PERCENT", "high_limit": 102.5, "low_limit": 97.5 }, "qualification": "USP", "type": "BASIS OF STRENGTH->SUBSTANCE", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "a8b6b682-559b-4d88-9ac3-ab34e1a0eb14" ], "related_substance": { "uuid": "f6ce51d9-a0b9-4544-a5f6-1c9771f0e655", "refuuid": "087f7c29-e973-41b7-889e-7952d8b02364", "name": "LIDOCAINE", "unii": "98PI200987", "linking_id": "98PI200987", "ref_pname": "LIDOCAINE", "substance_class": "reference" } }, { "uuid": "60d23add-f17e-47b8-9faf-0df1c4894f9a", "amount": { "uuid": "92ba5d17-4fff-4a3a-9838-e05106fff6ab", "units": "PERCENT PEAK AREA", "high_limit": 0.01 }, "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "8793fe37-1d7c-4ba3-8ee4-9a00f8d8ae2b" ], "related_substance": { "uuid": "1f795ca3-4680-49bb-9f77-572b862cd647", "refuuid": "0a8f9719-8332-4754-aacd-7cd3eb90fd35", "name": "2,6-Xylidine", "unii": "4FT62OX08D", "linking_id": "4FT62OX08D", "ref_pname": "2,6-Xylidine", "substance_class": "reference" } }, { "uuid": "95af1901-9b87-44e2-bf69-09a1504f23b9", "amount": { "uuid": "f3278085-1836-4380-9201-1c1a414e6310", "units": "PERCENT PEAK AREA", "high_limit": 0.1 }, "comments": "UNSPECIFIED", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "0ad4610c-3ce1-4a3f-bf38-072b8bdf5217", "8c7df00d-271a-e555-8280-d90d2b844aeb" ], "related_substance": { "uuid": "336441d3-7b49-4be1-a3f2-0fdc3d4592dd", "refuuid": "6d8b8bf8-e0ac-4c6e-8063-a84e0f0a67e0", "name": "LIDOCAINE N2-OXIDE", "unii": "25797M378Y", "linking_id": "25797M378Y", "ref_pname": "LIDOCAINE N2-OXIDE", "substance_class": "reference" } }, { "uuid": "1fba287d-ca8b-44e0-81e9-22ae51ab6e4f", "amount": { "uuid": "f689b425-53a0-415b-9e6b-0c26e4824547", "units": "PERCENT PEAK AREA", "high_limit": 0.1 }, "comments": "UNSPECIFIED", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "0ad4610c-3ce1-4a3f-bf38-072b8bdf5217", "8c7df00d-271a-e555-8280-d90d2b844aeb" ], "related_substance": { "uuid": "4b97344b-612d-42b5-871e-151da9128bb2", "refuuid": "09d2d158-7bb8-4966-b65a-7db4dbbef333", "name": "N-ACETYL-2,6-XYLIDINE", "unii": "68GZI4J9FM", "linking_id": "68GZI4J9FM", "ref_pname": "N-ACETYL-2,6-XYLIDINE", "substance_class": "reference" } }, { "uuid": "e217be36-9dad-463f-93fa-bc168f167569", "amount": { "uuid": "a0e7b7e6-23ef-48d6-9ce6-2c62392e7be8", "units": "PERCENT PEAK AREA", "high_limit": 0.1 }, "comments": "UNSPECIFIED", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "0ad4610c-3ce1-4a3f-bf38-072b8bdf5217", "8c7df00d-271a-e555-8280-d90d2b844aeb" ], "related_substance": { "uuid": "ba5dd07a-46c4-46be-8e01-8bb1bf44d72e", "refuuid": "d59d04c1-0979-4a84-8854-5938cd32ba1a", "name": "NORLIDOCAINE", "unii": "D8Q99HC770", "linking_id": "D8Q99HC770", "ref_pname": "NORLIDOCAINE", "substance_class": "reference" } }, { "uuid": "51e2fb35-d8a9-4b9e-96a1-ab0c271cfdf0", "amount": { "uuid": "cb039585-1853-486a-aba1-d601494b1ef2", "units": "PERCENT PEAK AREA", "high_limit": 0.1 }, "comments": "UNSPECIFIED", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "0ad4610c-3ce1-4a3f-bf38-072b8bdf5217", "8c7df00d-271a-e555-8280-d90d2b844aeb" ], "related_substance": { "uuid": "3d37ef4c-151a-40b5-84eb-203ea50aacd6", "refuuid": "e6ce7e31-e1b0-4ae6-899c-442a4414416a", "name": "2,2'-IMINOBIS(N-(2,6-DIMETHYLPHENYL)ACETAMIDE)", "unii": "8P3T7VI89U", "linking_id": "8P3T7VI89U", "ref_pname": "2,2'-IMINOBIS(N-(2,6-DIMETHYLPHENYL)ACETAMIDE)", "substance_class": "reference" } }, { "uuid": "57664697-7b66-4a4f-8e16-075b4cc9df4a", "amount": { "uuid": "5e342182-4cd8-415f-a96f-9008f50f1579", "units": "PERCENT PEAK AREA", "high_limit": 0.1 }, "comments": "UNSPECIFIED", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "0ad4610c-3ce1-4a3f-bf38-072b8bdf5217", "8c7df00d-271a-e555-8280-d90d2b844aeb" ], "related_substance": { "uuid": "a8fbcac1-70f3-4cc0-a2ff-1c41749e9590", "refuuid": "222768b9-796a-489f-8899-f62cf9d5155d", "name": "2-DIETHYLAMINO-2',3'-ACETOXYLIDIDE", "unii": "6451W1541N", "linking_id": "6451W1541N", "ref_pname": "2-DIETHYLAMINO-2',3'-ACETOXYLIDIDE", "substance_class": "reference" } }, { "uuid": "0099b450-2687-41e8-a666-d7bd620a3226", "amount": { "uuid": "4b6055c8-91c0-48c4-9869-b9106f013d7e", "units": "PERCENT PEAK AREA", "high_limit": 0.1 }, "comments": "UNSPECIFIED", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "0ad4610c-3ce1-4a3f-bf38-072b8bdf5217", "8c7df00d-271a-e555-8280-d90d2b844aeb" ], "related_substance": { "uuid": "35ae4df8-80a2-455a-95cc-ae074499d7c4", "refuuid": "5f3e59ac-696a-418c-b40e-28fb8138a39d", "name": "2-(ISOPROPYLAMINO)-2',6'-ACETOXYLIDIDE", "unii": "265CH520S5", "linking_id": "265CH520S5", "ref_pname": "2-(ISOPROPYLAMINO)-2',6'-ACETOXYLIDIDE", "substance_class": "reference" } }, { "uuid": "b36e87a0-e35a-4425-a6eb-424028613dd0", "amount": { "uuid": "2d04bed7-0c2d-49be-b8f8-f4a1f7689d7b", "units": "PERCENT PEAK AREA", "high_limit": 0.1 }, "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "666c86b6-49e5-47af-9b82-441e9756cc3e" ], "related_substance": { "uuid": "2ee1a645-db35-4336-aed5-e233d73d176a", "refuuid": "8ba46f89-5bd0-4819-a129-85678fd1ba1f", "name": "2-CHLORO-2',6'-ACETOXYLIDIDE", "unii": "5D2B69OAPX", "linking_id": "5D2B69OAPX", "ref_pname": "2-CHLORO-2',6'-ACETOXYLIDIDE", "substance_class": "reference" } }, { "uuid": "78750d18-66f3-438c-9546-9c97d99fad92", "amount": { "uuid": "7a94ed12-6423-4f2f-a222-47310ea497fc", "units": "PERCENT PEAK AREA", "high_limit": 0.1 }, "comments": "UNSPECIFIED", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "0ad4610c-3ce1-4a3f-bf38-072b8bdf5217", "8c7df00d-271a-e555-8280-d90d2b844aeb" ], "related_substance": { "uuid": "4b6d7327-91f7-45cb-8b64-82f336728a85", "refuuid": "7789f34d-5a50-40df-818e-41cdc6f8895f", "name": "2-(DIETHYLAMINO)-2',4'-ACETOXYLIDIDE", "unii": "1JI90526PD", "linking_id": "1JI90526PD", "ref_pname": "2-(DIETHYLAMINO)-2',4'-ACETOXYLIDIDE", "substance_class": "reference" } }, { "uuid": "5362c0bc-8a04-4e53-b7c5-1283aca72cd9", "amount": { "uuid": "156bf465-486f-4495-b27e-dfc5824d3236", "units": "PERCENT PEAK AREA", "high_limit": 0.1 }, "comments": "UNSPECIFIED", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "0ad4610c-3ce1-4a3f-bf38-072b8bdf5217", "8c7df00d-271a-e555-8280-d90d2b844aeb" ], "related_substance": { "uuid": "cbbce7a7-8c6c-42c2-89b0-9e10d3081015", "refuuid": "64a8aac4-ff70-489d-83a6-865096c2f287", "name": "2-DIETHYLAMINO-2',5'-ACETOXYLIDIDE", "unii": "KF2Q5P76DB", "linking_id": "KF2Q5P76DB", "ref_pname": "2-DIETHYLAMINO-2',5'-ACETOXYLIDIDE", "substance_class": "reference" } }, { "uuid": "cdbb31ae-630f-4d20-bc73-b2a6168e00f6", "amount": { "uuid": "9a49f0df-d883-4598-aacf-262b1e50adc8" }, "type": "METABOLITE LESS ACTIVE->PARENT", "related_substance": { "uuid": "310d9431-189a-42e2-b9fc-a4f4deae9be3", "refuuid": "d59d04c1-0979-4a84-8854-5938cd32ba1a", "name": "NORLIDOCAINE", "unii": "D8Q99HC770", "linking_id": "D8Q99HC770", "ref_pname": "NORLIDOCAINE", "substance_class": "reference" } }, { "uuid": "9cbdfef4-d504-40e5-b5da-ab3c62ccdda5", "amount": { "uuid": "7c73336b-c528-493b-b87a-9fae9a88c2bf" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "341a8652-eb9e-4ab8-9c5b-e6e92210ec35", "refuuid": "f92219c3-b57d-4f3c-b82e-6c8c56209b32", "name": "LIDOCAINE CARBONATE", "unii": "F0783GVP2Z", "linking_id": "F0783GVP2Z", "ref_pname": "LIDOCAINE CARBONATE", "substance_class": "reference" } }, { "uuid": "e22e945d-6588-4056-bda2-9020ee05d0f4", "amount": { "uuid": "22a76c01-46be-4f6e-8ac5-a3648e12f352" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "d230ad4a-2a23-4ea5-9277-ffad69baccb6", "refuuid": "cff3eead-46a1-4281-a8c6-ea2a42a55b31", "name": "LIDOCAINE HYDROCHLORIDE", "unii": "V13007Z41A", "linking_id": "V13007Z41A", "ref_pname": "LIDOCAINE HYDROCHLORIDE", "substance_class": "reference" } }, { "uuid": "8213223c-e3b4-40ea-bb6b-4c4c497be4ff", "amount": { "uuid": "3c4c7138-fe9e-4dc6-86dc-060a462b877f" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "00a9d67d-11f9-4b77-ad50-bb26ad2f4cb7", "refuuid": "ed717b41-0d67-408a-9e63-3e4114784f09", "name": "LIDOCAINE HYDROCHLORIDE ANHYDROUS", "unii": "EC2CNF7XFP", "linking_id": "EC2CNF7XFP", "ref_pname": "LIDOCAINE HYDROCHLORIDE ANHYDROUS", "substance_class": "reference" } }, { "uuid": "9a52c10d-50d4-4d03-99e6-4caa685d6df2", "amount": { "uuid": "6a9a3585-3781-48dd-947c-deed3dbcb14b" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "a6575d7d-a1a0-4b75-949c-d3ad76c44869", "refuuid": "96e507a8-52f2-488b-977b-cb313fde9e42", "name": "LIDOCAINE MALEATE", "unii": "1WNS1NP35X", "linking_id": "1WNS1NP35X", "ref_pname": "LIDOCAINE MALEATE", "substance_class": "reference" } }, { "uuid": "863db8fd-be1d-4840-bcaa-329c8460b501", "amount": { "uuid": "d8a35f27-7a3a-4f69-9d32-0353a9e4c8cd" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "3f1d951d-230c-4010-9f94-a545d0342f32", "refuuid": "4148f3ff-40d2-4c75-a86f-75a677c222b9", "name": "LIDOCAINE TOSYLATE", "unii": "M0335SFO80", "linking_id": "M0335SFO80", "ref_pname": "LIDOCAINE TOSYLATE", "substance_class": "reference" } }, { "uuid": "993e9076-1c2a-4ed0-b93e-1e2d28ba4229", "amount": { "uuid": "81a7ef02-0775-402e-adb5-b610170d78aa" }, "comments": "has unknown pharmacologic activity but is carcinogenic in rats (http://srsid.fda.gov:9618/ePS/SubstanceRelationship.do?substanceMode=update&calledFrom=viewUpdateIngredient&RELATIONSHIP_ID=128538&SUBSTANCE_ID=1422&BDNUM=0021807AA).", "qualification": "PLASMA", "type": "METABOLITE INACTIVE->PARENT", "references": [ "04b4ced8-66be-4dbe-b960-c45539c376f6" ], "related_substance": { "uuid": "6e10cab8-ab0e-4eb3-a72d-ae7cddfbf0db", "refuuid": "0a8f9719-8332-4754-aacd-7cd3eb90fd35", "name": "2,6-Xylidine", "unii": "4FT62OX08D", "linking_id": "4FT62OX08D", "ref_pname": "2,6-Xylidine", "substance_class": "reference" } }, { "uuid": "e87b091a-df6e-4ae1-b414-6e006f2c2873", "amount": { "uuid": "abec4178-6cda-4248-aeb2-c0eae194eaa4" }, "comments": "major excreted metabolite.", "qualification": "URINE", "type": "METABOLITE INACTIVE->PARENT", "interaction_type": "MAJOR", "references": [ "04b4ced8-66be-4dbe-b960-c45539c376f6" ], "related_substance": { "uuid": "357334cb-7956-4c1b-b916-9ece27531073", "refuuid": "d5f05717-10d3-4bae-8203-372322c5eb0c", "name": "4-AMINO-3,5-DIMETHYLPHENOL", "unii": "1S8G005MHP", "linking_id": "1S8G005MHP", "ref_pname": "4-AMINO-3,5-DIMETHYLPHENOL", "substance_class": "reference" } }, { "uuid": "7071a8a8-5765-4ed9-ba87-f142692cbf5f", "amount": { "uuid": "b255ba2a-4a70-43de-b4e6-9a1705e4fede" }, "qualification": "PLASMA", "type": "METABOLITE LESS ACTIVE->PARENT", "references": [ "8b7c555e-33e1-4cb1-ae8d-3aa1a6f42265", "24785329-1e93-43e5-8489-a79fc52eb0f9" ], "related_substance": { "uuid": "46794dab-d650-49b9-9303-32097e9bd95c", "refuuid": "9f687427-8aba-4eb1-9a44-9e92417757db", "name": "GLYCINEXYLIDIDE", "unii": "D2D932W316", "linking_id": "D2D932W316", "ref_pname": "GLYCINEXYLIDIDE", "substance_class": "reference" } }, { "uuid": "9428e3ee-3f7d-4617-80a5-5aada979c61e", "amount": { "uuid": "4b85539e-9ba2-4ea7-b022-199ea163ab36" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "8370b06d-a9a7-446d-ac78-59026a2ebf75", "refuuid": "f5e99005-b75c-4690-a057-4770b85b1f56", "name": "LIDOCAINE IMINODIACETIC ACID", "unii": "FAO4HZ1165", "linking_id": "FAO4HZ1165", "ref_pname": "LIDOCAINE IMINODIACETIC ACID" } }, { "uuid": "47e08f80-7e86-49ee-a52a-5d6ddfbd4405", "amount": { "uuid": "e739bb35-d6b8-4ea7-ba8a-acd72f63ed12", "average": 55, "units": "%" }, "type": "BINDER->LIGAND", "interaction_type": "BINDING", "references": [ "94df265b-277c-e42a-6ff0-93b8c5c892cf" ], "related_substance": { "uuid": "36e7f59a-b164-4d3d-88ea-d63fdc25cd33", "refuuid": "e95d330b-4c2d-44bb-a61b-860afeb4aa30", "name": "PLASMA PROTEIN FRACTION (HUMAN)", "unii": "6D53G0FD0Z", "linking_id": "6D53G0FD0Z", "ref_pname": "PLASMA PROTEIN FRACTION (HUMAN)", "substance_class": "reference" } }, { "uuid": "89a75cc3-a489-4b48-9344-e6f61756582d", "amount": { "uuid": "9cb24362-1698-444e-9548-e9ae2ace34c9", "units": "PERCENT PEAK AREA", "high_limit": 0.01 }, "qualification": "USP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "9a675430-629d-5c59-447b-4e55c41fe29b" ], "related_substance": { "uuid": "70cd0532-cb8c-48c3-a78d-f73411c0dde8", "refuuid": "0a8f9719-8332-4754-aacd-7cd3eb90fd35", "name": "2,6-Xylidine", "unii": "4FT62OX08D", "linking_id": "4FT62OX08D", "ref_pname": "2,6-Xylidine", "substance_class": "reference" } }, { "uuid": "b5bb2676-d629-44bf-9dc2-11161f522e0d", "amount": { "uuid": "79329fdb-a98a-4280-86c1-14c703c04de1", "units": "PERCENT PEAK AREA", "high_limit": 0.1 }, "qualification": "USP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "9a675430-629d-5c59-447b-4e55c41fe29b" ], "related_substance": { "uuid": "815f165c-2eea-4c3b-8703-3b9eb867f87e", "refuuid": "8ba46f89-5bd0-4819-a129-85678fd1ba1f", "name": "2-CHLORO-2',6'-ACETOXYLIDIDE", "unii": "5D2B69OAPX", "linking_id": "5D2B69OAPX", "ref_pname": "2-CHLORO-2',6'-ACETOXYLIDIDE", "substance_class": "reference" } }, { "uuid": "44bb5ea4-ff3b-475f-8c81-e2ed5b1ca15b", "amount": { "uuid": "7b9270b8-f6ac-4163-9ea1-1ced8fd30dd6" }, "type": "METABOLIC ENZYME->SUBSTRATE", "references": [ "30f68adc-03b7-48c7-9a40-03c10de2fb0a" ], "related_substance": { "uuid": "e89a23df-6036-4f53-a346-5e53ffeaa025", "refuuid": "bef2e27e-8cd7-4739-89f8-096dd2941aa0", "name": "CYTOCHROME P450 2E1", "unii": "03BYF220B6", "linking_id": "03BYF220B6", "ref_pname": "CYTOCHROME P450 2E1", "substance_class": "reference" } }, { "uuid": "4a010249-6966-4f23-998d-153291e981a5", "amount": { "uuid": "aee1c064-a0c9-4481-b983-3b6523f41291" }, "type": "METABOLIC ENZYME->SUBSTRATE", "references": [ "1e040dbe-12b8-4ab1-a250-528b748be901" ], "related_substance": { "uuid": "9f4be44e-72bb-42ba-8ee6-9aec8cc124de", "refuuid": "57f7f4d0-c1da-417a-aa04-f047d0da8e09", "name": "LIVER CARBOXYLESTERASE 1", "unii": "HPN66MJEK8", "linking_id": "HPN66MJEK8", "ref_pname": "LIVER CARBOXYLESTERASE 1", "substance_class": "reference" } }, { "uuid": "eb500438-5e33-45d8-9c5d-0afd89faee3a", "amount": { "uuid": "d6bcb53e-ed6b-4010-8636-10543734215f" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "e019d967-4eb6-4432-8452-74b23ae93295", "refuuid": "beeba0ec-f03a-484b-9520-18dbf792aeb7", "name": "LIDOCAINE SULFATE", "unii": "EYR84TH492", "linking_id": "EYR84TH492", "ref_pname": "LIDOCAINE SULFATE" } }, { "uuid": "68d43d52-d339-4cd0-8f8d-bb5f6f79c4a4", "amount": { "uuid": "fb64dc99-f0bb-4301-acbc-fb02f97d794c" }, "type": "METABOLITE->PARENT", "references": [ "43528574-f9e6-48bd-87f2-627674417232" ], "related_substance": { "uuid": "95e56ad4-80e1-42e8-a611-63c3c1f2000a", "refuuid": "81588fb2-8922-449f-9cf3-ce0bc91f9bdf", "name": "2,6-DIMETHYLPHENYLHYDROXYLAMINE", "unii": "GQ8EDF3D00", "linking_id": "GQ8EDF3D00", "ref_pname": "2,6-DIMETHYLPHENYLHYDROXYLAMINE" } }, { "uuid": "d5b27a79-7529-42ca-bf45-41096e855946", "amount": { "uuid": "13492025-bab6-4c55-9be9-4d9d028608a2" }, "qualification": "URINE", "type": "METABOLITE->PARENT", "interaction_type": "MAJOR", "references": [ "e8f8d5c4-fcc0-42ef-a209-aec5b3f6bdb9" ], "related_substance": { "uuid": "8ef32b79-4cd5-4833-ad9a-07c67a68e198", "refuuid": "e6b7b6e3-c522-4169-91b3-6963a7e7cc93", "name": "2,6-DIMETHYLACETAMINOPHEN", "unii": "R7R7KO00SW", "linking_id": "R7R7KO00SW", "ref_pname": "2,6-DIMETHYLACETAMINOPHEN" } }, { "uuid": "47f7e5e0-052a-4b36-8482-1faf8f326bbb", "amount": { "uuid": "13ea1ddc-547c-4b42-ae0b-28934ca9aa3a", "average": 69.8, "high": 74.8, "low": 64.8, "units": "%" }, "type": "BINDER->LIGAND", "interaction_type": "BINDING", "references": [ "29c12beb-88f1-43fa-a1aa-88ce0cadb012" ], "related_substance": { "uuid": "0382a7a0-61a6-4216-9285-d60c673aa404", "refuuid": "e95d330b-4c2d-44bb-a61b-860afeb4aa30", "name": "PLASMA PROTEIN FRACTION (HUMAN)", "unii": "6D53G0FD0Z", "linking_id": "6D53G0FD0Z", "ref_pname": "PLASMA PROTEIN FRACTION (HUMAN)", "substance_class": "reference" } }, { "uuid": "550f6223-c4f0-4577-909b-baaa4e6b053b", "amount": { "uuid": "e281ff7c-6842-4396-8bee-ce2fba287fa5" }, "comments": "Inhibits other VGSC channels.", "type": "TARGET->INHIBITOR", "references": [ "e359e2c5-a498-4f41-add6-d2c5641b1434" ], "related_substance": { "uuid": "7496112c-9bc3-4230-854c-d3dc53697523", "refuuid": "7ce8de6e-75b5-474a-ba0c-8e96fc932a03", "name": "SODIUM CHANNEL PROTEIN TYPE 1 SUBUNIT ALPHA", "unii": "PIV978KC1N", "linking_id": "PIV978KC1N", "ref_pname": "SODIUM CHANNEL PROTEIN TYPE 1 SUBUNIT ALPHA", "substance_class": "reference" } } ], "names": [ { "uuid": "625450e3-f9bf-4ca0-b4e8-36b3c346f96b", "name": "2-(DIETHYLAMINO)-2',6'-ACETOXYLIDIDE", "stdName": "2-(DIETHYLAMINO)-2',6'-ACETOXYLIDIDE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "fa2728bf-222f-4ae5-aec0-54df9414ebb4" ], "display_name": false }, { "uuid": "1f440569-b952-4fe1-aa09-a99f4597a351", "name": "2-(DIETHYLAMINO)-N-(2,6-DIMETHYLPHENYL)ACETAMIDE", "stdName": "2-(DIETHYLAMINO)-N-(2,6-DIMETHYLPHENYL)ACETAMIDE", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "f0ed48fb-7e10-491e-8af0-7dea864e7ed7" ], "display_name": false }, { "uuid": "f941199f-dde5-420a-9ef6-3284bcc19bf9", "name": "2-DIETHYLAMINO-2',6'-ACETOXYLIDIDE", "stdName": "2-DIETHYLAMINO-2',6'-ACETOXYLIDIDE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "f0ed48fb-7e10-491e-8af0-7dea864e7ed7" ], "display_name": false }, { "uuid": "ebd3dde7-857b-4298-9b69-c8344e4aafa1", "name": "ACETAMIDE, 2-(DIETHYLAMINO)-N-(2,6-DIMETHYLPHENYL)-", "stdName": "ACETAMIDE, 2-(DIETHYLAMINO)-N-(2,6-DIMETHYLPHENYL)-", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "fa2728bf-222f-4ae5-aec0-54df9414ebb4" ], "display_name": false }, { "uuid": "bda0ddb0-91c7-4e15-ab4e-6a7fd300c436", "name": "ALGRX 3268", "stdName": "ALGRX 3268", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "5fbfd2f4-3b15-4451-afc8-59a478de2b67" ], "display_name": false }, { "uuid": "e9aa6656-c4cf-4590-b27e-d3e5ded5d707", "name": "ALGRX-3268", "stdName": "ALGRX-3268", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "5fbfd2f4-3b15-4451-afc8-59a478de2b67" ], "display_name": false }, { "uuid": "e930430f-b7aa-4c83-8c35-88e9fd7cea42", "name": "ALPHACAINE", "stdName": "ALPHACAINE", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "5eef161b-6bd8-4a55-bbac-39a361265896" ], "display_name": false }, { "uuid": "80fe6b6e-f940-4d62-9e04-881829c53b9b", "name": "DENTIPATCH", "stdName": "DENTIPATCH", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "3c79f50c-8d3a-454f-b214-47d68fa85576" ], "display_name": false }, { "uuid": "718ad777-40b8-4e3a-a15c-9f9827ce314d", "name": "DIETHYLAMINO-2,6-DIMETHYLACETANILIDE", "stdName": "DIETHYLAMINO-2,6-DIMETHYLACETANILIDE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "f0ed48fb-7e10-491e-8af0-7dea864e7ed7" ], "display_name": false }, { "uuid": "1fd71011-02d7-40aa-94b1-1776285ead00", "name": "EMLA COMPONENT LIDOCAINE", "stdName": "EMLA COMPONENT LIDOCAINE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "a8fb229b-6c4d-42c1-a217-1cbf70c741b2", "30b82b41-ff34-48a0-a941-b52489a84686" ], "display_name": false }, { "uuid": "656492a3-8ba2-467e-866e-2ad543a0a31a", "name": "FORTACIN COMPONENT LIDOCAINE", "stdName": "FORTACIN COMPONENT LIDOCAINE", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "a3cf2787-de43-4015-bb3f-b1198fb066b5" ], "display_name": false }, { "uuid": "4c0f72bb-7d78-4754-a227-e0e1ab43d1f5", "name": "LANABIOTIC COMPONENT LIDOCAINE", "stdName": "LANABIOTIC COMPONENT LIDOCAINE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "a8fb229b-6c4d-42c1-a217-1cbf70c741b2", "30b82b41-ff34-48a0-a941-b52489a84686" ], "display_name": false }, { "uuid": "5b3beabf-54bd-4766-8f39-b85de7f27c4f", "name": "LIDOCAINE", "stdName": "LIDOCAINE", "type": "of", "languages": [ "en" ], "preferred": false, "references": [ "f25e8b21-c5c8-4488-ffeb-29d4bf08f7d7", "ae859173-e1aa-4942-b302-1d5b3fa6de36", "78b6ba3a-0c92-449d-9c02-ddac1af84d86", "229076c8-1cf3-4d4c-b621-77e044790772", "156354d8-1525-46d6-a6ca-4e3a8244942c", "7eaa5290-1f2f-46e2-b64b-6bb81415215a", "b9715576-c29a-4d1a-9c06-95f3deb58b0a", "b3f4863a-abae-4924-bd65-c00c704d8ec6", "8d42964d-c89a-415d-a435-8c97425aae2e", "b6fdacc6-7cb2-4ef3-bf20-d131eb5d1cf6", "05187042-7df8-4be4-82d9-381e740b7780", "24a5ca0b-47ba-4b43-8e07-4984598abeba", "212c8c7e-5672-41a1-93b1-705f9f46c352", "b51c8423-411f-4f38-85ca-69fad4b9193d", "cd9a9ace-ab5f-402b-8d40-78fe7472ce38", "22da41c7-5dc9-4e7d-bbb8-0c8bd257bf6c", "8087e2a9-1e5f-492a-a447-9970b0c19645", "57eda33a-f62d-4543-82f0-cc272f0ec4c1", "bef4f229-e00d-43bc-9823-c39ee3fe8987", "e181bd06-4d42-45a2-a28f-f1a28a01fdb5", "b3d1377e-0b7f-4787-a50e-9208fc9f5106", "e40e9af9-1428-4931-988a-f4cf5be33465", "b031dbc7-c397-487e-9407-a25ff007aca9", "cf74b85b-cf89-4454-bcc2-3eccb42c3480", "717312e4-de02-4022-bdb4-47b42d535afc", "88d8b0da-1ba9-4764-9eed-562f3100580a", "1a3ab3e9-998e-42aa-8c35-79aec4ca26a3" ], "display_name": true, "domains": [ "drug", "cosmetic" ], "name_orgs": [ { "uuid": "98b8d3eb-a5e5-4a6a-80a7-810f3a745712", "name_org": "INN" }, { "uuid": "c9018525-4e08-4e17-ae4a-df23413c532a", "name_org": "INCI" } ] }, { "uuid": "5a099f82-c968-b741-9d5e-b784117ca60e", "name": "LIDOCAINE [EP MONOGRAPH]", "stdName": "LIDOCAINE [EP MONOGRAPH]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "809499b3-0580-1c2f-38e3-cdac7758b67b" ], "display_name": false }, { "uuid": "c0b68ae6-00aa-45d3-9eba-cb4837aa9a76", "name": "LIDOCAINE [GREEN BOOK]", "stdName": "LIDOCAINE [GREEN BOOK]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "8d42964d-c89a-415d-a435-8c97425aae2e" ], "display_name": false }, { "uuid": "004cbefa-1962-4981-b177-3d38229383a3", "name": "LIDOCAINE [HSDB]", "stdName": "LIDOCAINE [HSDB]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "05187042-7df8-4be4-82d9-381e740b7780" ], "display_name": false }, { "uuid": "bf3bcc12-293c-4c0a-b4aa-cb75ba548b71", "name": "LIDOCAINE [JAN]", "stdName": "LIDOCAINE [JAN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "8f1cba26-4d47-6baa-c8f6-375c09baba84" ], "display_name": false }, { "uuid": "9a9552fb-3c3c-4ef7-bdbd-09d547f4ebba", "name": "LIDOCAINE [MART.]", "stdName": "LIDOCAINE [MART.]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "b9715576-c29a-4d1a-9c06-95f3deb58b0a" ], "display_name": false }, { "uuid": "7eca6972-f64f-4816-891f-ff081f3c4bd1", "name": "LIDOCAINE [MI]", "stdName": "LIDOCAINE [MI]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "b3f4863a-abae-4924-bd65-c00c704d8ec6" ], "display_name": false }, { "uuid": "9cec2cc6-7ce9-481f-a4e0-cc8bfcc2bf51", "name": "LIDOCAINE [ORANGE BOOK]", "stdName": "LIDOCAINE [ORANGE BOOK]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "7eaa5290-1f2f-46e2-b64b-6bb81415215a" ], "display_name": false }, { "uuid": "899a6004-0feb-4b0e-75ab-4b427e64c197", "name": "LIDOCAINE [USP MONOGRAPH]", "stdName": "LIDOCAINE [USP MONOGRAPH]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "e75ba3b1-d99d-f05b-6d5a-6f1f2571487e" ], "display_name": false }, { "uuid": "7e1b4686-d265-47d3-85dc-174fc0307f28", "name": "LIDOCAINE [USP-RS]", "stdName": "LIDOCAINE [USP-RS]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "24a5ca0b-47ba-4b43-8e07-4984598abeba" ], "display_name": false }, { "uuid": "80c477be-d943-45c2-8254-0eadaa242eda", "name": "LIDOCAINE [VANDF]", "stdName": "LIDOCAINE [VANDF]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "b51c8423-411f-4f38-85ca-69fad4b9193d" ], "display_name": false }, { "uuid": "4e3fb8cf-ec18-4418-8e47-132701d86fc8", "name": "LIDOCAINE [WHO-IP]", "stdName": "LIDOCAINE [WHO-IP]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "cd9a9ace-ab5f-402b-8d40-78fe7472ce38" ], "display_name": false }, { "uuid": "fd587741-59b1-42bf-b1ca-1e884aa72177", "name": "LIDOCAINUM [WHO-IP LATIN]", "stdName": "LIDOCAINUM [WHO-IP LATIN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "cd9a9ace-ab5f-402b-8d40-78fe7472ce38" ], "display_name": false }, { "uuid": "c9215058-a018-42ec-b9e5-bd5d238e12b0", "name": "LIDODERM", "stdName": "LIDODERM", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "5eef161b-6bd8-4a55-bbac-39a361265896" ], "display_name": false }, { "uuid": "55eff23b-7c11-4b0a-b065-7c3b971d2e5e", "name": "LIGNOCAINE", "stdName": "LIGNOCAINE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "fa2728bf-222f-4ae5-aec0-54df9414ebb4" ], "display_name": false }, { "uuid": "91587758-3e43-e1c9-ae08-a83c2dc9300b", "name": "Lidocaine [WHO-DD]", "stdName": "LIDOCAINE [WHO-DD]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "7ac5392d-6b44-5fb1-1be2-d43d18604232" ], "display_name": false }, { "uuid": "e38b9662-9461-479d-8556-689fe9529fe0", "name": "NSC-40030", "stdName": "NSC-40030", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "f24e59fb-762f-4fdf-a7ce-792c9a2e0035" ], "display_name": false }, { "uuid": "9c0a0de0-6859-44a4-bf23-8968b89b61cc", "name": "ORAQIX COMPONENT LIDOCAINE", "stdName": "ORAQIX COMPONENT LIDOCAINE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "a8fb229b-6c4d-42c1-a217-1cbf70c741b2", "30b82b41-ff34-48a0-a941-b52489a84686" ], "display_name": false }, { "uuid": "b722709e-96a3-44ec-9bcb-265b6d143796", "name": "ROCEPHIN KIT COMPONENT LIDOCAINE", "stdName": "ROCEPHIN KIT COMPONENT LIDOCAINE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "a8fb229b-6c4d-42c1-a217-1cbf70c741b2", "30b82b41-ff34-48a0-a941-b52489a84686" ], "display_name": false }, { "uuid": "f9dbca87-b45e-4d2f-aad1-b3dbbfbd336f", "name": "SOLARCAINE", "stdName": "SOLARCAINE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "f24e59fb-762f-4fdf-a7ce-792c9a2e0035" ], "display_name": false }, { "uuid": "a1fdd7c0-4425-41f9-b1eb-7e1f3a1c4a85", "name": "SYNERA COMPONENT LIDOCAINE", "stdName": "SYNERA COMPONENT LIDOCAINE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "a8fb229b-6c4d-42c1-a217-1cbf70c741b2", "30b82b41-ff34-48a0-a941-b52489a84686" ], "display_name": false }, { "uuid": "5dc6af0e-b6c2-4b02-ae20-e04375806645", "name": "XYLESTESIN", "stdName": "XYLESTESIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "f24e59fb-762f-4fdf-a7ce-792c9a2e0035" ], "display_name": false }, { "uuid": "cb0b4648-2c61-4e9b-ae10-320ba33377b2", "name": "XYLOCAINE", "stdName": "XYLOCAINE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "5b2a32d8-db87-41b8-9ace-4da9eccf6748" ], "display_name": false }, { "uuid": "2b21e93f-ab99-11a7-9545-b881e723584d", "name": "ZTLIDO", "stdName": "ZTLIDO", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "2e460475-fb38-3986-9487-e1b4763ae2ae" ], "display_name": false }, { "uuid": "03396eba-ce46-4397-834d-82c5bc2b2e56", "name": "lidocaine [INN]", "stdName": "LIDOCAINE [INN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "78b6ba3a-0c92-449d-9c02-ddac1af84d86" ], "display_name": false } ], "properties": [ { "uuid": "d9957891-ec65-420e-ab14-7e94d232700f", "name": "Volume of Distribution", "value": { "uuid": "fe3bee7e-8b13-40ba-8d7c-f18fd0019384", "average": 1.6, "high": 2.1, "low": 1.1, "units": "Liters/Kilogram" }, "defining": false, "parameters": [ { "uuid": "c1c46edd-5ebd-48f4-b1de-f00fe01f26d5", "name": "Crosses blood-brain barrier", "references": [] } ], "property_type": "PHARMACOKINETIC", "references": [ "af3ee059-b0ca-9538-ce62-3146e0ca47c4" ] } ] } ] }